Designed for clinicians, scientists, and all other members of the cancer care and research community, this three-day meeting focuses on clinical and translational advances in immuno-oncology. At the 2018 Symposium, expert faculty will offer new insights on the application of immunotherapy in melanoma, lung cancer, genitourinary cancers, head and neck cancer, and hematologic malignancies. Faculty will also discuss considerations for clinical trial designs, treatment of microsatellite instability high solid tumors, and emerging targets in immunotherapy.
Each day of the 2018 program will feature a Keynote Lecture given by world-renowned experts on exciting topics in immuno-oncology, including the future of the field, genomics of the immune response in cancer, and cellular therapy for cancer.
For members of the cancer care team looking for a foundational understanding of immunology, the Symposium will also feature early morning “Immunology 101” sessions. During “Evening Highlights” sessions, expert clinicians will help further contextualize the educational content provided throughout the program for clinical application.
The meeting will also offer several opportunities for robust networking, discussion, and engagement with faculty members and other attendees. Participants in Networking Roundtable sessions will interact with leaders in the field to discuss research and treatment in all of the disease-sites covered by the educational program. During the Trainee and Early-Career Networking Luncheon, faculty will lead small-group discussions on the clinical application of immuno-oncology specifically tailored for early-career attendees.